Search

for
Search:

Experts

1 / 1 results

Hair Transplant Surgeon
Dr. Olivier Beckers
Hasselt, Belgium

Clinics

6 / 7 results

All 7 clinic results →

Research

5 / 1000+ results

research Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)

March 2026 in “Figshare”

This study identified distinct and significant adverse event patterns across different drug classes used to treat benign prostatic hyperplasia, confirming known risks and suggesting novel safety signals for further investigation.

research Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)

March 2026 in “Figshare”

This study analyzed the FDA Adverse Event Reporting System and found distinct safety signals and adverse event patterns among α1-blockers, 5α-reductase inhibitors, and tadalafil used in treating benign prostatic hyperplasia, emphasizing known risks and identifying potential new ones that require further study.

research Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)

March 2026 in “The Aging Male”

This retrospective pharmacovigilance study reviewed adverse event reports from 2004 to 2025 for drugs treating benign prostatic hyperplasia, identifying distinct safety signals for α1-blockers, 5ARIs, and PDE5I, including some potential new adverse events that require further investigation.

research Review: Adding α₁-blockers to 5α-reductase inhibitors improves lower urinary tract symptoms in men

March 2014 in “Annals of Internal Medicine”

This review found that adding α1-blockers to 5α-reductase inhibitors may improve lower urinary tract symptoms in men with non-neurogenic conditions, based on existing evidence.

research A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms.

52 citations , January 2005 in “PubMed”

This study concluded that alpha(1)-adrenoceptor antagonists are more effective than finasteride in the short term for reducing symptoms of lower urinary tract symptoms associated with benign prostatic hyperplasia.

View more "a-1 blockers" in research →

Community Join

5 / 1000+ results

community 1 Month of 10%Minoxidil + Finastride Solution, DHT Blocker Hair Gummies, 1mm derma roller. What do you think? I had Hair Transplant done, close to 5 years before. Stopped Minoxidil 1 year before. Started this Treatment again. My Dermatologist said I will not grow a single strand of hair.

in Is this regrowth? 71 upvotes 1 year ago

The user resumed a hair loss treatment with 10% minoxidil, finasteride solution, DHT blocker hair gummies, and a 1mm derma roller after stopping minoxidil a year ago, despite a dermatologist's skepticism about regrowth. Users suggest avoiding gummies, considering oral dutasteride, and maintaining finasteride use for better results.

community Happy with progress! 1+ yr regrowth- DHT blockers and Minoxidil

in Progress Pictures 125 upvotes 1 year ago

The user experienced significant hair regrowth using dutasteride, oral minoxidil, and ketoconazole shampoo, with no side effects except denser facial hair. They increased their dosages to 1mg dutasteride and 5mg oral minoxidil for better results.

community My doctor prescribed me 1/4 of a 2.5mg pill of minoxidil daily

in Minoxidil 11 upvotes 4 months ago

A dermatologist prescribed 0.625mg of oral minoxidil daily without a DHT blocker, which some users disagree with, suggesting a combination with finasteride or dutasteride for better results. Others argue starting with a low dose of minoxidil is standard to test tolerance before considering additional treatments.

community Winlevi 1% Cream - Lets See how it goes

3 upvotes 2 months ago

The conversation is about using Winlevi 1% cream, Pyri (Koshine) 0.5%, and minoxidil for hair loss treatment. The user is hopeful for results with Winlevi but is sensitive to 5AR blockers.

community Close Up of 1.5 months progress. Minox + 0.5mm Derma Stamp + Caffeine Serum

in Progress Pictures 2 upvotes 4 months ago

The conversation discusses hair loss treatment progress using Minoxidil, a 0.5mm derma stamp, and caffeine serum, with additional use of rosemary, peppermint, and olive oil. The user is avoiding DHT blockers like Finasteride due to potential interference with other medications.

View more "a-1 blockers" in community →

Learn

7 / 800 results

learn tamsulosin

What is tamsulosin and how is it used in treatments related to hair loss? Tamsulosin is a prescription alpha-1 blocker approved for benign prostatic hyperplasia; no human trial has tested it for hair loss, and there are no dosing protocols or safety data for that use. Its connection to hair is a receptor-biology hypothesis, not a treatment.

learn Tripeptide-1

learn Biotinoyl tripeptide 1

learn copper tripeptide-1

learn 1,2-Hexanediol

learn Ketoconazole

Is there a difference between 1% and 2% ketoconazole? The documented differences are strength and supply: 1% ketoconazole shampoo is sold over the counter while 2% is usually prescription-only, and almost all of the trial evidence — including a 2015 Cochrane review — was gathered on the 2% shampoo rather than in a head-to-head comparison of the two strengths.

learn Biotin

Biotin, Biotinyl-GHK, biotinoyl-tripeptide-1… are they not the same? Biotin, Biotinyl-GHK, and Biotinoyl-Tripeptide-1 are different compounds with distinct functions.

View more "a-1 blockers" in learn →

Dr. Olivier Beckers